NewsBenzingaMedifast Lowers FY2026 GAAP EPS Guidance from $(1.75)-$(0.25) to $(2.05)-$(1.80) vs $(0.94) Est Medifast Lowers FY2026 GAAP EPS Guidance from $(1.75)-$(0.25) to $(2.05)-$(1.80) vs $(0.94) Est Benzinga 2026.10.26 12:09 (GMT+0) Open on Benzinga Other news MasTec Suspends Talks For Proposed Acquisition Opportunity To Prioritize $250M Stock Buyback Plan Bernstein Maintains Market Perform on McDonald's, Raises Price Target to $280 Appian CEO Says US Government Is Embracing AI Efficiency As Federal Deals Grow Bernstein Maintains Outperform on Performance Food Group, Raises Price Target to $135 Bernstein Maintains Market Perform on Edwards Lifesciences, Raises Price Target to $106 Datadog Posts Q3 Beat, Q4 Revenue Guide Implies 1st Sequential Growth Decline Since 2019
